Similarly, the expression of GINS2 mRNA was significantly higher in collected glioma samples than paraneoplastic tissues, as evidenced by reverse transcription–quantitative PCR (RT–qPCR) (Supplementary Fig. 2A, B, P < 0.05). This evidence concerns the gene GINS2 and central nervous system cancer.